Drugs / FTC/RPV/TDF
last change Oct 2014 re-read 2 minutes ago

FTC/RPV/TDF

Developed for
HIV infectious disease
Investigated by
Gilead Sciences

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01252940 Nov 2010 → Jan 2012 HIV infectious disease Gilead Sciences Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FTC/RPV/TDF ClinicalTrials.gov intervention name — accepted as the source's own label NCT01252940
Route Oral “administered orally with a meal once daily (QD)” NCT01252940